| Cefpodoxime proxetil |
№ ІІ-10281/16.07.2010 |
Ximebac, Oral suspension, 40 mg/5ml - 100 ml, -, Pack: 1 |
Sandoz d.d., Словения |
Sandoz GmbH |
9.21 |
1.84 |
11.05 |
7% |
0.64 |
9.85 |
1.97 |
11.82 |
20% |
1.84 |
11.69 |
2.34 |
14.03 |
НСР-2236/20.12.2013 |
04.01.2014 |
04.01.2014 |
|
|
Активен |
980 |
| Cefpodoxime proxetil |
№ ІІ-10279/16.07.2010 |
Ximebac, Film coated tablet, 100 mg, -, Pack: 10 |
Sandoz d.d., Словения |
Sandoz GmbH |
8.61 |
1.72 |
10.33 |
7% |
0.6 |
9.21 |
1.84 |
11.05 |
20% |
1.72 |
10.93 |
2.19 |
13.12 |
НСР-2238/20.12.2013 |
04.01.2014 |
04.01.2014 |
|
|
Активен |
977 |
| Cefpodoxime proxetil |
№ ІІ-10280/16.07.2010 |
Ximebac, Film coated tablet, 200 mg, -, Pack: 10 |
Sandoz d.d., Словения |
Sandoz GmbH |
15.65 |
3.13 |
18.78 |
6% |
0.94 |
16.59 |
3.32 |
19.91 |
18% |
2.82 |
19.41 |
3.88 |
23.29 |
НСР-2237/20.12.2013 |
04.01.2014 |
04.01.2014 |
|
|
Активен |
978 |
| Cefpodoxime proxetil |
20100472 |
Ximebac, Film coated tablet, 100 mg, -, Pack: 20 |
Sandoz d.d., Словения |
Sandoz GmbH, Австрия |
31.25 |
6.25 |
37.5 |
4% |
1.25 |
32.5 |
6.5 |
39 |
16% |
5 |
37.5 |
7.5 |
45 |
НСР-1306/03.10.2013 |
25.10.2013 |
25.10.2013 |
промяна в обстоятелствата НСР-1572/01.11.2013 |
|
Активен |
8484 |
| Cefpodoxime proxetil |
20100473 |
Ximebac, Film coated tablet, 200 mg, -, Pack: 14 |
Sandoz d.d., Словения |
Sandoz GmbH, Австрия |
25.88 |
5.18 |
31.06 |
6% |
1.55 |
27.43 |
5.49 |
32.92 |
18% |
4.66 |
32.09 |
6.42 |
38.51 |
НСР-1306/03.10.2013 |
25.10.2013 |
25.10.2013 |
промяна в обстоятелствата НСР-1572/01.11.2013 |
|
Активен |
8485 |
| Radium (Ra²²³) dichloride |
EU/1/13/873/001 |
Xofigo, Solution for injection, 1000 kBq/ml - 6 ml, -, Pack: 1 |
Bayer AG, Германия |
Bayer AS, Норвегия |
8605.65 |
1721.13 |
10326.78 |
4% |
10 |
8615.65 |
1723.13 |
10338.78 |
16% |
25 |
8640.65 |
1728.13 |
10368.78 |
НСР-4113/10.07.2014 |
25.07.2014 |
02.12.2017 |
Промяна на обстоятелства НСР-14212/19.10.2017 |
|
Активен |
8899 |
| Radium (Ra²²³) dichloride |
EU/1/13/873/001 |
Xofigo, Solution for injection, 1000 kBq/ml - 6 ml, -, Pack: 1 |
Bayer Pharma AG, Германия |
Algeta ASA, Норвегия |
8605.65 |
1721.13 |
10326.78 |
4% |
10 |
8615.65 |
1723.13 |
10338.78 |
16% |
25 |
8640.65 |
1728.13 |
10368.78 |
НСР-4113/10.07.2014 |
25.07.2014 |
25.07.2014 |
|
|
Неактивен |
8899 |
| Cefuroxime |
20060578 |
Xorimax, Coated tablet, 250 mg, -, Pack: 12 |
Sandoz GmbH, Австрия |
Sandoz GmbH, Австрия |
9.39 |
1.88 |
11.27 |
7% |
0.66 |
10.05 |
2.01 |
12.06 |
20% |
1.88 |
11.93 |
2.39 |
14.32 |
НСР-2755/17.02.2014 |
06.03.2014 |
06.03.2014 |
|
|
Активен |
8756 |
| Cefuroxime |
20060579 |
Xorimax, Coated tablet, 500 mg, -, Pack: 12 |
Sandoz GmbH, Австрия |
Sandoz GmbH, Австрия |
23.57 |
4.71 |
28.28 |
6% |
1.41 |
24.98 |
5 |
29.98 |
18% |
4.24 |
29.22 |
5.84 |
35.06 |
НСР-2755/17.02.2014 |
06.03.2014 |
06.03.2014 |
|
|
Активен |
8757 |
| Cefuroxime |
ІІ-14615/23.10.2006 г. |
XORIMAX, Coated tablet, 250 mg, -, Pack: 10 |
Sandoz GmbH, Австрия |
Sandoz GmbH Austria |
7.12 |
1.42 |
8.54 |
7% |
0.5 |
7.62 |
1.52 |
9.14 |
20% |
1.42 |
9.04 |
1.81 |
10.85 |
КЦ-136/ / 04,07,2008 г. |
29.07.2008 |
29.07.2008 |
|
|
Активен |
7151 |
| Cefuroxime |
ІІ-14616/23.10.2006 г. |
XORIMAX, Coated tablet, 500 mg, -, Pack: 10 |
Sandoz GmbH, Австрия |
Sandoz GmbH Austria |
14.32 |
2.86 |
17.18 |
6% |
0.86 |
15.18 |
3.04 |
18.22 |
18% |
2.58 |
17.76 |
3.55 |
21.31 |
КЦ-136/ / 04,07,2008 г. |
29.07.2008 |
29.07.2008 |
|
|
Активен |
7152 |
| Sennae acutifoliae fructus extr. sicc. normatum |
20020506 |
X-PREP, Oral solution, 2.34g/75 ml, -, Pack: 1 |
Mundipharma GmbH, Австрия |
Mundipharma GmbH, Germany |
4.44 |
0.89 |
5.33 |
7% |
0.31 |
4.75 |
0.95 |
5.7 |
20% |
0.89 |
5.64 |
1.13 |
6.77 |
НСР-2263/21.12.2013 |
27.01.2014 |
27.01.2014 |
|
|
Активен |
8670 |
| Dalbavancin |
EU/1/14/ 986/001 |
Xydalba, powder for concetrate for solution for infusion, 500 mg, -, Pack: 1 |
Durata Therapeu-tics Internatio-nal B.V., Нидерландия |
Almac Pharma Services Ltd, UK |
1486.43 |
297.29 |
1783.72 |
4% |
10 |
1496.43 |
299.29 |
1795.72 |
16% |
25 |
1521.43 |
304.29 |
1825.72 |
НСР-7288/29.10.2015. |
14.11.2015 |
14.11.2015 |
|
|
Активен |
9145 |
| Lidocaine, Chlorhexidine |
II-1947/17,04,2008 |
XYLODREN BROWN, Solution for injection, 2 ml, -, Pack: 10 |
Софарма АД, България |
СОФАРМА АД |
5.76 |
1.15 |
6.91 |
7% |
0.4 |
6.16 |
1.23 |
7.39 |
20% |
1.15 |
7.31 |
1.46 |
8.77 |
КЦ-131/ / 23,06,2008 г. |
22.07.2008 |
22.07.2008 |
|
|
Активен |
7957 |
| Lidocaine, Chlorhexidine |
II-1947/17,04,2008 |
XYLODREN BROWN, Solution for injection, 2 ml, -, Pack: 50 |
Софарма АД, България |
СОФАРМА АД |
28.79 |
5.76 |
34.55 |
6% |
1.73 |
30.52 |
6.1 |
36.62 |
18% |
5.18 |
35.7 |
7.14 |
42.84 |
КЦ-131/ / 23,06,2008 г. |
22.07.2008 |
22.07.2008 |
|
|
Активен |
7956 |
| Xylometazoline |
20050202 |
XYLOGEL, nasal gel, 0,1 % - 10 g, -, Pack: 1 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Полша |
5.09 |
1.02 |
6.11 |
7% |
0.36 |
5.45 |
1.09 |
6.54 |
20% |
1.02 |
6.47 |
1.29 |
7.76 |
НСР-1019/23.08.2013; НСР-12853/26.05.2017 |
19.09.2013 |
02.07.2017 |
|
|
Заличен |
8394 |
| Xylometazoline |
20050201 |
XYLOGEL, nasal gel, 0,05 % - 10 g, -, Pack: 1 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Полша |
3.72 |
0.74 |
4.46 |
7% |
0.26 |
3.98 |
0.8 |
4.78 |
20% |
0.74 |
4.72 |
0.94 |
5.66 |
НСР-1020/23.08.2013; НСР-11580/26.01.2017 |
19.09.2013 |
02.03.2017 |
|
|
Заличен |
8395 |
| Xylometazoline hydrochloride |
20050202 |
XYLOGEL, nasal gel, 0,1 % - 10 g, -, Pack: 1 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Полша |
5.09 |
1.02 |
6.11 |
7% |
0.36 |
5.45 |
1.09 |
6.54 |
20% |
1.02 |
6.47 |
1.29 |
7.76 |
НСР-1019/23.08.2013 |
19.09.2013 |
19.09.2013 |
|
|
Неактивен |
8394 |
| Xylometazoline hydrochloride |
20050201 |
XYLOGEL, nasal gel, 0,05 % - 10 g, -, Pack: 1 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Полша |
3.72 |
0.74 |
4.46 |
7% |
0.26 |
3.98 |
0.8 |
4.78 |
20% |
0.74 |
4.72 |
0.94 |
5.66 |
НСР-1020/23.08.2013 |
19.09.2013 |
19.09.2013 |
|
|
Неактивен |
8395 |
| Xylometazoline |
20030702 |
XYLOMETAZOLIN WZF, nasal drops, solution, 0,1 % - 10 ml, -, Pack: 1 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Полша |
1.6 |
0.32 |
1.92 |
7% |
0.11 |
1.71 |
0.34 |
2.05 |
20% |
0.32 |
2.03 |
0.41 |
2.44 |
НСР-1021/23.08.2013; НСР-12852/26.05.2017 |
19.09.2013 |
02.07.2017 |
|
|
Заличен |
8396 |
| Xylometazoline hydrochloride |
20030702 |
XYLOMETAZOLIN WZF, nasal drops, solution, 0,1 % - 10 ml, -, Pack: 1 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Полша |
1.6 |
0.32 |
1.92 |
7% |
0.11 |
1.71 |
0.34 |
2.05 |
20% |
0.32 |
2.03 |
0.41 |
2.44 |
НСР-1021/23.08.2013 |
19.09.2013 |
19.09.2013 |
|
|
Неактивен |
8396 |
| Xylometazoline hydrochloride |
20030701 |
XYLOMETAZOLIN WZF, nasal drops, solution, 0,05 % - 10 ml, -, Pack: 1 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa SA, Полша |
1.08 |
0.22 |
1.3 |
7% |
0.08 |
1.16 |
0.23 |
1.39 |
20% |
0.22 |
1.38 |
0.28 |
1.66 |
НСР-1022/23.08.2013 |
19.09.2013 |
19.09.2013 |
|
|
Активен |
8397 |
| Ethinylestradiol, Drospirenone |
II-14288/27.09.2006 / 20010803 |
YASMIN, Film coated tablet, 0,03 mg/3 mg, -, Pack: 21 |
Bayer Schering Pharma AG,, Германия |
Bayer Schering Pharma AG, Germany; / Schering GmbH and Co Produktion KG, Germany |
10.8 |
2.16 |
12.96 |
6% |
0.65 |
11.45 |
2.29 |
13.74 |
18% |
1.94 |
13.39 |
2.68 |
16.07 |
КЦ-352/ / 19,12,2008 г. |
22.01.2009 |
22.01.2009 |
|
|
Активен |
8053 |
| Donepezil |
20070118 |
YASNAL, Film coated tablet, 5 mg, -, Pack: 28 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Slovenia; TAD Pharma GmbH, Германия |
7.92 |
1.58 |
9.5 |
7% |
0.55 |
8.47 |
1.69 |
10.16 |
20% |
1.58 |
10.05 |
2.01 |
12.06 |
НСР-8303/26.02.2016 |
02.04.2016 |
02.04.2016 |
|
|
Активен |
1725 |
| Donepezil |
20070119 |
YASNAL, Film coated tablet, 10 mg, -, Pack: 28 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Slovenia; TAD Pharma GmbH, Германия |
11.89 |
2.38 |
14.27 |
6% |
0.71 |
12.6 |
2.52 |
15.12 |
18% |
2.14 |
14.74 |
2.95 |
17.69 |
НСР-8304/26.02.2016 |
02.04.2016 |
02.04.2016 |
|
|
Активен |
1724 |